Levofloxacin Alternatives Compared
| Levofloxacin | Clarithromycin | Ceftriaxone |
|
|---|
| Levofloxacin | Clarithromycin | Ceftriaxone |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Levofloxacin treats a wide range of bacterial infections; however, it can cause some very severe and potentially irreversible side effects such as tendonitis or tendon rupture and should only be used... View more |
Prescribed for Dental Abscess, Bronchitis, Bacterial Endocarditis Prevention, Helicobacter Pylori Infection, Legionella Pneumonia, Mycobacterium avium-intracellulare - Prophylaxis, Mycobacterium... View more |
Prescribed for Bacterial Infection, Bone infection, Bacterial Endocarditis Prevention, Bacteremia, Bronchitis, Chancroid, Conjunctivitis, Endocarditis, Endometritis, Epididymitis - Non-Specific... View more |
Choose a suggestion below Skin or Soft Tissue Infection
|
|||||||||||||||||||||||
| More about Levofloxacin | More about Clarithromycin | More about Ceftriaxone | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Availability | ||||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Levofloxacin has an average rating of 5.1 out of 10 from a total of 699 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 45% reported a negative effect. |
Clarithromycin has an average rating of 5.4 out of 10 from a total of 777 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 36% reported a negative effect. |
Ceftriaxone has an average rating of 8.5 out of 10 from a total of 147 ratings on Drugs.com. 82% of reviewers reported a positive effect, while 9% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See the full levofloxacin side effects document. |
Commonly reported side effects include: dysgeusia. See the full clarithromycin side effects document. |
See the full ceftriaxone side effects document. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all levofloxacin prices |
View all clarithromycin prices |
View all ceftriaxone prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Levaquin | Biaxin XL |
N/A |
||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
6 hours |
7 hours |
8 hours |
||||||||||||||||||||||||
| CSA Schedule** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 468 drugs are known to interact with levofloxacin:
|
A total of 645 drugs are known to interact with clarithromycin:
|
A total of 39 drugs are known to interact with ceftriaxone:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
December 20, 1996 |
October 31, 1991 |
December 21, 1984 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.